This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2007-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mishima-gun, JP (2007 - 2012)
- Osaka, JP (2017)
Company Filing History:
Years Active: 2007-2017
Title: Masahiko Terakado: Innovator in Pharmaceutical Compounds
Introduction
Masahiko Terakado is a notable inventor based in Mishima-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of 5 patents to his name, Terakado's work is recognized for its potential impact on medical treatments.
Latest Patents
One of Terakado's latest inventions is an ALXR agonist compound. This compound exhibits ALXR agonist activity and is designed to prevent and treat ALXR-associated diseases, including inflammatory bowel disease, autoimmune diseases, chronic inflammatory diseases, asthma, pulmonary fibrosis, atopic dermatitis, ischemia-reperfusion injury, myocardial infarction, and Alzheimer's disease. Another significant patent is for an LPA receptor antagonist. This compound is useful in the prevention and treatment of various urinary system diseases, carcinoma-associated diseases, proliferative diseases, inflammation and immune system diseases, brain-related diseases, and chronic diseases.
Career Highlights
Masahiko Terakado is currently employed at Ono Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of complex medical conditions.
Collaborations
Throughout his career, Terakado has collaborated with esteemed colleagues, including Takuya Seko and Shinji Nakade. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Masahiko Terakado's contributions to pharmaceutical innovation are noteworthy, with a focus on developing compounds that address critical health issues. His ongoing work at Ono Pharmaceutical Co., Ltd. continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile